Product Information
CEFIXIME 400 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $9.9173 per EA under NDC 68180042308. Its NADAC has been published 175 times since Feb 22, 2023.
FDA first approved this application on Jun 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180042308
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFIXIMEApproval Type
Authorized Generic (NDA)
FDA Application
NDA203195FDA Approved
6/1/2012
TE Code
AB
On Market Since
10/14/2020
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 400 MG CAPSULE has been published 175 times since Feb 22, 2023, and over the history we have for it it has declined 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.9173 per EA |
|---|---|
| All-time high | $10.7608 (Feb 14, 2024) |
| All-time low | $9.2307 (Aug 21, 2024) |
| 52-week high | $10.7437 |
| 52-week low | $9.9173 |
| Median price | $10.0927 |
| Average price | $10.1556 |
| Largest weekly change | -7.3% (Apr 17, 2024) |
| Weeks tracked | 175 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFIXIME 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 400 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $9.9173 per EA (NDC 68180042308), effective Aug 19, 2026.
How has the price of CEFIXIME 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFIXIME 400 MG CAPSULE has declined 7.8%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for CEFIXIME 400 MG CAPSULE?
Since Feb 22, 2023, the NADAC for CEFIXIME 400 MG CAPSULE has ranged from a low of $9.2307 (Aug 21, 2024) to a high of $10.7608 (Feb 14, 2024), with a median of $10.0927 per EA.
Are there cheaper alternatives to CEFIXIME 400 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFIXIME 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFIXIME 400 MG CAPSULE?
CEFIXIME 400 MG CAPSULE (NDC 68180042308) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.